Literature DB >> 28450381

Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma.

Shuichiro Aoki1, Hiroshi Murata1, Yuri Fujino2, Masato Matsuura3, Atsuya Miki4, Masaki Tanito5, Shiro Mizoue6,7, Kazuhiko Mori8, Katsuyoshi Suzuki9, Takehiro Yamashita10, Kenji Kashiwagi11, Kazunori Hirasawa12, Nobuyuki Shoji13, Ryo Asaoka14.   

Abstract

BACKGROUND/AIMS: To investigate the usefulness of the Octopus (Haag-Streit) EyeSuite's cluster trend analysis in glaucoma.
METHODS: Ten visual fields (VFs) with the Humphrey Field Analyzer (Carl Zeiss Meditec), spanning 7.7 years on average were obtained from 728 eyes of 475 primary open angle glaucoma patients. Mean total deviation (mTD) trend analysis and EyeSuite's cluster trend analysis were performed on various series of VFs (from 1st to 10th: VF1-10 to 6th to 10th: VF6-10). The results of the cluster-based trend analysis, based on different lengths of VF series, were compared against mTD trend analysis. RESULT: Cluster-based trend analysis and mTD trend analysis results were significantly associated in all clusters and with all lengths of VF series. Between 21.2% and 45.9% (depending on VF series length and location) of clusters were deemed to progress when the mTD trend analysis suggested no progression. On the other hand, 4.8% of eyes were observed to progress using the mTD trend analysis when cluster trend analysis suggested no progression in any two (or more) clusters.
CONCLUSION: Whole field trend analysis can miss local VF progression. Cluster trend analysis appears as robust as mTD trend analysis and useful to assess both sectorial and whole field progression. Cluster-based trend analyses, in particular the definition of two or more progressing cluster, may help clinicians to detect glaucomatous progression in a timelier manner than using a whole field trend analysis, without significantly compromising specificity. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cluster; glaucoma; progression

Mesh:

Year:  2017        PMID: 28450381     DOI: 10.1136/bjophthalmol-2016-310069

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

Review 1.  Functional assessment of glaucoma: Uncovering progression.

Authors:  Rongrong Hu; Lyne Racette; Kelly S Chen; Chris A Johnson
Journal:  Surv Ophthalmol       Date:  2020-04-26       Impact factor: 6.048

2.  Structure-Function Relationship between Cluster Mean Defect and Sector Peripapillary Retinal Nerve Fiber Layer Thickness in Primary Open Angle Glaucoma.

Authors:  Jing Han; Wenjiu Yang; Dabo Wang; Haiqing Bai
Journal:  J Ophthalmol       Date:  2022-07-11       Impact factor: 1.974

3.  Development and validation of a visual field cluster in retinitis pigmentosa.

Authors:  Takashi Omoto; Akio Oishi; Ryo Asaoka; Yuri Fujino; Hiroshi Murata; Keiko Azuma; Manabu Miyata; Ryo Obata; Tatsuya Inoue
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

4.  Pointwise and Region-Wise Course of Visual Field Loss in Patients With Glaucoma.

Authors:  Samaneh Sabouri; Saeedeh Pourahmad; Koenraad A Vermeer; Hans G Lemij; Siamak Yousefi
Journal:  Transl Vis Sci Technol       Date:  2022-07-08       Impact factor: 3.048

5.  A Joint Multitask Learning Model for Cross-sectional and Longitudinal Predictions of Visual Field Using OCT.

Authors:  Ryo Asaoka; Linchuan Xu; Hiroshi Murata; Taichi Kiwaki; Masato Matsuura; Yuri Fujino; Masaki Tanito; Kazuhiko Mori; Yoko Ikeda; Takashi Kanamoto; Kenji Inoue; Jukichi Yamagami; Kenji Yamanishi
Journal:  Ophthalmol Sci       Date:  2021-09-07

Review 6.  Ganglion Cell Complex Analysis in Glaucoma Patients: What Can It Tell Us?

Authors:  Gianluca Scuderi; Serena Fragiotta; Luca Scuderi; Clemente Maria Iodice; Andrea Perdicchi
Journal:  Eye Brain       Date:  2020-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.